Active Ingredient
Salicylic Acid 2%
The following Structured Product Label (SPL) was submitted to the FDA by Galderma Laboratories, L.p. for the product Cetaphil Gentle Clear Pore Clearing Acne Cleanser (NDC 0299-4143). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, use, warnings, when using this product, stop use and ask a doctor if, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Salicylic Acid 2%
Acne Treatment
For the management of acne
For external use only
• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
• irritation becomes severe.
If swallowed, get medical help or contact a Poison Control Center right away.
Apply to dampened skin and gently massage. Rinse thoroughly with warm water. Pat dry. If bothersome dryness or peeling occurs, reduce application use.
BENZYL ALCOHOL, BUTYROSPERMUM PARKII (SHEA) BUTTER, COCAMIDOPROPYL BETAINE, GLYCERIN, GLYCINE SOJA (SOYBEAN) OIL, GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE, HYDROGENATED SOYBEAN OIL, HYDROXYPROPYL STARCH PHOSPHATE, LACTIC ACID, LAURIC ACID, PALMITIC ACID, PHENOXYETHANOL, SODIUM BENZOATE, SODIUM CHLORIDE, SODIUM HYDROXIDE, SODIUM LAUROYL GLYCINATE, SODIUM LAUROYL ISETHIONATE, STEARIC ACID, TETRASODIUM EDTA, WATER
Distributed by:
Galderma Laboratories, L.P.
Dallas, TX 75201 USA
All trademarks are the property
of their respective owners.
cetaphil.com
NEW
Cetaphil®
ACNE
Gentle Clear
Pore Clearing Acne Cleanser
2% Salicylic Acid Acne Treatment
Gently clears breakouts and provides
24-hour dryness relief
Salicylic Acid
Advanced Moisture Blend
Dermatologist Recommended
Sencitive Skin
8 FL OZ (237 mL)
P57613-0
* Please review the disclaimer below.